Home  |  Slider   |  Media   |  Bharat Biotech, Occugen to co-develop Covaxin for US

Bharat Biotech, Occugen to co-develop Covaxin for US

Vaccine maker Bharat Biotech has inked a binding letter of intent (LoI) with US-based biopharmaceutical player Ocugen Inc for co-developing India’s first indigenous Covid-19 vaccine candidate Covaxin for the US market.Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News

The post Bharat Biotech, Occugen to co-develop Covaxin for US appeared first on Planotech Media House.

WRITTEN BY: